inBio
Intomics has been providing state-of-the-art data analysis and interpretation for more than a decade to world-leading pharma and biotech companies. We are now making a significant expansion to our product portfolio by launching the inBioTM platform.
inBioTM is a unique new platform for biological data analysis and interpretation with applications across the drug discovery and development pipeline for pharma and biotech companies. With its combination of high-complexity analysis capabilities and ease-of-use this platform allows you to discover novel biological associations. The platform builds upon a unique, proprietary map of protein biology, inBio MapTM, which provides high-confidence information about the biology and interplay of almost 14.000 proteins. The inBioTM platform has been developed in close cooperation with leading pharma companies to ensure that it offers optimal value across a number of key applications.